Edwards Lifesciences (EW) Inventory Average (2010 - 2026)

Edwards Lifesciences' Inventory Average history runs 17 years deep, the most recent figure standing at $1.1 billion for Q1 2026.

• In Q1 2026, Inventory Average rose 2.03% year-over-year to $1.1 billion; the TTM figure through Mar 2026 stood at $1.1 billion (up 2.03% YoY), while the FY2025 annual figure was $1.1 billion, up 11.19% from the prior year.
• Inventory Average was $1.1 billion for Q1 2026 at Edwards Lifesciences, down from $1.1 billion in the prior quarter.
• In the past five years, Inventory Average ranged from a high of $1.1 billion in Q3 2025 to a low of $728.6 million in Q1 2022.
• Historically, Inventory Average has averaged $988.4 million across 5 years, with a median of $1.1 billion in 2024.
• The sharpest annual moves came in 2022 and 2023: Inventory Average declined 7.19% in 2022, then soared 34.37% in 2023.
• A 5-year view of Inventory Average shows it stood at $816.6 million in 2022, then rose by 18.53% to $968.0 million in 2023, then increased by 13.17% to $1.1 billion in 2024, then climbed by 3.48% to $1.1 billion in 2025, then retreated by 0.97% to $1.1 billion in 2026.
• The last three Inventory Average figures came in at $1.1 billion (Q1 2026), $1.1 billion (Q4 2025), and $1.1 billion (Q3 2025), per Business Quant data.